Showing results (241-250 of 699) with videos related to
Sort By:
Pageof 70
American Journal of Hematology|July 8, 2023
Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myelomaSaurabh Zanwar, Matthew Ho, Yi Lin, et al.Hematology/Oncology Clinics of North America|May 28, 2023
Evaluation and Management of Disease Transformation in Waldenström MacroglobulinemiaDipti Talaulikar, Cécile Tomowiak, Elise Toussaint, et al.Blood Cancer Journal|March 14, 2018
Defining cure in multiple myeloma: a comparative study of outcomes of young individuals with myeloma and curable hematologic malignanciesPraful Ravi, Shaji K Kumar, James R Cerhan, et al.Blood|July 19, 2011
Incidence, clinical course, and prognosis of secondary monoclonal gammopathy of undetermined significance in patients with multiple myelomaRishi K Wadhera, Robert A Kyle, Dirk R Larson, et al.Blood|May 16, 2002
Diagnostic and prognostic value of bone marrow angiogenesis and megakaryocyte c-Mpl expression in essential thrombocythemiaRuben A Mesa, Curtis A Hanson, Chin-Yang Li, et al.Blood|July 10, 2015
Melphalan, prednisone, and thalidomide vs melphalan, prednisone, and lenalidomide (ECOG E1A06) in untreated multiple myelomaA Keith Stewart, Susanna Jacobus, Rafael Fonseca, et al.The New England Journal of Medicine|January 18, 2018
Long-Term Follow-up of Monoclonal Gammopathy of Undetermined SignificanceRobert A Kyle, Dirk R Larson, Terry M Therneau, et al.Blood Cancer Journal|September 8, 2018
Lenalidomide and dexamethasone in patients with relapsed multiple myeloma and impaired renal function: PrE1003, a PrECOG studyJoseph Mikhael, Judith Manola, Amylou C Dueck, et al.Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|December 19, 2022
The impact of Post-Transplant doxycycline in AL amyloidosis - updated results after Long-Term follow upNadine Abdallah, Angela Dispenzieri, Eli Muchtar, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 3, 2015
The impact of dialysis on the survival of patients with immunoglobulin light chain (AL) amyloidosis undergoing autologous stem cell transplantationNelson Leung, Shaji K Kumar, Siobhan V Glavey, et al.Pageof 70